Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Hôpital Necker-Enfants Malades
Paris, France
Inserm
Paris, France
Masih Daneshvari Hospital
Tehran, Iran
Shahid Beheshti University
Tehran, Iran
Tehran University of Medical Sciences
Tehran, Iran
Children's Medical Center
Tehran, Iran
Alborz University of Medical Sciences
Karaj, Iran
Children's Hospital of Chongqing Medical University
Chongqing, China
Rockefeller University
New York, United States
Hiroshima University
Hiroshima, Japan
References
References (43)
- 1
Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin vaccination against tuberculosis in Iranian children.
Mahmoudi S, Khaheshi S, Pourakbari B, et al.
Clinical and experimental vaccine research 2015; (4(2)):195-9 doi:10.7774/cevr.2015.4.2.195.
PMID: 26273579 - 2
Disseminated Bacillus Calmette-Guérin and Susceptibility to Mycobacterial Infections-Implications on Bacillus Calmette-Guérin Vaccinations.
Lee PP
Annals of the Academy of Medicine, Singapore 2015; (44(8)):297-301.
PMID: 26477962 - 3
Not the End of the Odyssey: Parental Perceptions of Whole Exome Sequencing (WES) in Pediatric Undiagnosed Disorders.
Rosell AM, Pena LD, Schoch K, et al.
Journal of genetic counseling 2016; (25(5)):1019-31 doi:10.1007/s10897-016-9933-1.
PMID: 26868367 - 4
Australian children living with rare diseases: experiences of diagnosis and perceived consequences of diagnostic delays.
Zurynski Y, Deverell M, Dalkeith T, et al.
Orphanet journal of rare diseases 2017; (12(1)):68 doi:10.1186/s13023-017-0622-4.
PMID: 28399928 - 5
Frequency of Mycobacterium bovis and mycobacteria in primary immunodeficiencies.
Ulusoy E, Karaca NE, Aksu G, et al.
Turk pediatri arsivi 2017; (52(3)):138-144 doi:10.5152/TurkPediatriArs.2017.5240.
PMID: 29062247 - 6
Disseminated Tuberculosis and Chronic Mucocutaneous Candidiasis in a Patient with a Gain-of-Function Mutation in Signal Transduction and Activator of Transcription 1.
Pedraza-Sánchez S, Lezana-Fernández JL, Gonzalez Y, et al.
Frontiers in immunology 2017; (8()):1651 doi:10.3389/fimmu.2017.01651.
PMID: 29270166 - 7
Laboratory evaluation of the IFN-γ circuit for the molecular diagnosis of Mendelian susceptibility to mycobacterial disease.
Esteve-Solé A, Sologuren I, Martínez-Saavedra MT, et al.
Critical reviews in clinical laboratory sciences 2018; (55(3)):184-204 doi:10.1080/10408363.2018.1444580.
PMID: 29502462 - 8
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy.
Ivashkiv LB
Nature reviews. Immunology 2018; (18(9)):545-558 doi:10.1038/s41577-018-0029-z.
PMID: 29921905 - 9
Molecular, Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease.
Sarrafzadeh SA, Nourizadeh M, Mahloojirad M, et al.
Journal of clinical immunology 2019; (39(3)):287-297 doi:10.1007/s10875-019-0593-4.
PMID: 30715640 - 10
A Syrian Refugee in Iraq Diagnosed as a Case of IL12RB1 Deficiency in Japan Using Dried Blood Spots.
Al-Kzayer LFY, Yassin AK, Salih KH, et al.
Frontiers in immunology 2019; (10()):58 doi:10.3389/fimmu.2019.00058.
PMID: 30740107 - 11
Safety and tolerability of moxifloxacin for the treatment of disseminated BCGitis in children.
Alsuhaibani M, Felimban G, Shoukri M, et al.
International journal of pediatrics & adolescent medicine 2019; (6(2)):47-50 doi:10.1016/j.ijpam.2019.01.003.
PMID: 31388545 - 12
Loss of Janus Associated Kinase 1 Alters Urothelial Cell Function and Facilitates the Development of Bladder Cancer.
Daza-Cajigal V, Albuquerque AS, Pearson J, et al.
Frontiers in immunology 2019; (10()):2065 doi:10.3389/fimmu.2019.02065.
PMID: 31552026 - 13
Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review.
Anand K, Burns EA, Ensor J, et al.
Clinical lymphoma, myeloma & leukemia 2020; (20(1)):18-23 doi:10.1016/j.clml.2019.08.008.
PMID: 31699655 - 14
Inherited human IFN-γ deficiency underlies mycobacterial disease.
Kerner G, Rosain J, Guérin A, et al.
The Journal of clinical investigation 2020; (130(6)):3158-3171.
PMID: 32163377 - 15
Waiting for a diagnosis in Rubinstein-Taybi: The journey from "ignorance is bliss" to the value of "a label".
Withers CM, Fleming J, Wallingford CK, et al.
American journal of medical genetics. Part A 2021; (185(1)):105-111 doi:10.1002/ajmg.a.61920.
PMID: 33063426 - 16
Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.
Zhang W, Chen X, Gao G, et al.
Frontiers in immunology 2021; (12()):654406 doi:10.3389/fimmu.2021.654406.
PMID: 33777053 - 17
Disseminated Mycobacterium simiae Infection in a Patient with Complete IL-12p40 Deficiency.
Mahdaviani SA, Marjani M, Jamee M, et al.
Iranian journal of allergy, asthma, and immunology 2021; (20(3)):376-381 doi:10.18502/ijaai.v20i3.6339.
PMID: 34134458 - 18
Outcome of Hematopoietic Stem Cell Transplantation in patients with Mendelian Susceptibility to Mycobacterial Diseases.
Radwan N, Nademi Z, Lum SH, et al.
Journal of clinical immunology 2021; (41(8)):1774-1780 doi:10.1007/s10875-021-01116-1.
PMID: 34387798 - 19
Mendelian susceptibility to mycobacterial disease in tuberculosis-hyperendemic South Africa.
Cornelissen HM, Glanzmann B, Van Coller A, et al.
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 2021; (111(10)):998-1005 doi:10.7196/SAMJ.2021.v111i10.15341.
PMID: 34949297 - 20
Effective anti-mycobacterial treatment for BCG disease in patients with Mendelian Susceptibility to Mycobacterial Disease (MSMD): a case series.
Mahdaviani SA, Fallahi M, Jamee M, et al.
Annals of clinical microbiology and antimicrobials 2022; (21(1)):8 doi:10.1186/s12941-022-00500-y.
PMID: 35232430 - 21
Mendelian susceptibility to mycobacterial diseases: state of the art.
Noma K, Mizoguchi Y, Tsumura M, Okada S
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2022; (28(11)):1429-1434 doi:10.1016/j.cmi.2022.03.004.
PMID: 35283318 - 22
Genetic and Functional Identifying of Novel STAT1 Loss-of-Function Mutations in Patients with Diverse Clinical Phenotypes.
Chen X, Chen J, Chen R, et al.
Journal of clinical immunology 2022; (42(8)):1778-1794 doi:10.1007/s10875-022-01339-w.
PMID: 35976469 - 23
Partial human Janus kinase 1 deficiency predominantly impairs responses to interferon gamma and intracellular control of mycobacteria.
Daza-Cajigal V, Albuquerque AS, Young DF, et al.
Frontiers in immunology 2022; (13()):888427 doi:10.3389/fimmu.2022.888427.
PMID: 36159783 - 24
Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS.
Liu X, Zhu X, Zhou X, et al.
Frontiers in immunology 2022; (13()):1012643 doi:10.3389/fimmu.2022.1012643.
PMID: 36263041 - 25
Novel STAT1 Variants in Japanese Patients with Isolated Mendelian Susceptibility to Mycobacterial Diseases.
Ono R, Tsumura M, Shima S, et al.
Journal of clinical immunology 2023; (43(2)):466-478 doi:10.1007/s10875-022-01396-1.
PMID: 36336768 - 26
Fibrosing mediastinitis in a child with Mendelian susceptibility to mycobacterial disease possibly due to Bacillus Calmette-Guérin.
Sharifinejad N, Mahdaviani SA, Fallah S, et al.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):96 doi:10.1186/s13223-022-00738-3.
PMID: 36397171 - 27
Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.
Errami A, Baghdadi JE, Ailal F, et al.
Journal of clinical immunology 2023; (43(4)):728-740 doi:10.1007/s10875-022-01419-x.
PMID: 36630059 - 28
A rare mutation causing autosomal dominant STAT1 deficiency in a South African multiplex kindred with disseminated BCG infection.
Greybe L, Leung D, Wieselthaler N, et al.
BMC pediatrics 2023; (23(1)):378 doi:10.1186/s12887-023-04206-8.
PMID: 37516851 - 29
Mendelian susceptibility to mycobacterial diseases: State of the puzzle.
Errami A, Bousfiha AA
Qatar medical journal 2023; (2023(2)):25 doi:10.5339/qmj.2023.sqac.25.
PMID: 38025345 - 30
Genetic, immunologic, and clinical features of 830 patients with Mendelian susceptibility to mycobacterial diseases (MSMD): A systematic review.
Khavandegar A, Mahdaviani SA, Zaki-Dizaji M, et al.
The Journal of allergy and clinical immunology 2024; (153(5)):1432-1444 doi:10.1016/j.jaci.2024.01.021.
PMID: 38341181 - 31
An atypical mycobacterial infection while on Janus kinase inhibitor therapy.
Valek SA, Black TA, Aboul-Fettouh N, Rogge MN
Dermatology online journal 2025; (31(2)) doi:10.5070/D331265289.
PMID: 40991493 - 32
Clinical recommendations for diagnosis and management of Mendelian susceptibility to mycobacterial disease in resource-limited settings.
Cornelissen H, Glanzmann B, van Coller A, et al.
The journal of allergy and clinical immunology. Global 2025; (4(4)):100540 doi:10.1016/j.jacig.2025.100540.
PMID: 41048447 - 33
Job's not done: BCG-itis as the first manifestation of hyper-IgE syndrome. A case report and review of the literature.
Staines-Boone AT, Venegas-Montoya E, García Campos JA, et al.
Clinical immunology (Orlando, Fla.) 2026; (282()):110639 doi:10.1016/j.clim.2025.110639.
PMID: 41242409 - 34
Case report: IL12RB1 deficiency in an infant with disseminated Bacille Calmette-Guérin disease.
Ma X, Chen J, Cheng J, Wang J
Frontiers in immunology 2025; (16()):1728612 doi:10.3389/fimmu.2025.1728612.
PMID: 41668770 - 35
What We Have Here Is a Failure to Communicate: Interleukin-12 / Interferon-gamma Axis Defects and Mendelian Susceptibility to Mycobacterial Disease.
Johnston AΜ, Rider NL, Freeman AF, et al.
The journal of allergy and clinical immunology. In practice 2026; (14(7)):1529-1539 doi:10.1016/j.jaip.2026.02.026.
PMID: 41786143 - 36
Characteristics of Mycobacterial, COVID-19, and Talaromyces Marneffei Infections in Patients with IL12RB1 and IFNGR1 Mutations in Western China.
Zhang W, Zhang Z, Liu C, et al.
Journal of clinical immunology 2026; (46(1)).
PMID: 41957131 - 37
Pseudotumoral Pulmonary Mycobacterium avium Disease in a Patient on Ruxolitinib Therapy.
Constantin AA, Iorga AL, Gaburici AD, Leonte I
Diagnostics (Basel, Switzerland) 2026; (16(7)) doi:10.3390/diagnostics16071069.
PMID: 41975780 - 38
Mendelian susceptibility to mycobacterial disease: IFN-γ-driven immunity collapse underlies heterogeneous infections.
Qian M, Zhou J, Zhou Q, et al.
Frontiers in immunology 2026; (17()):1781297 doi:10.3389/fimmu.2026.1781297.
PMID: 42183200 - 39
Disseminated BCGosis in immunocompromised infants: a five-case series in the context of a national BCG vaccination policy change.
Alhusaini W, Sanyour G, Kutbi R, et al.
BMC pediatrics 2026; (26(1)).
PMID: 42337472 - 40
Lymph Node Cytology Raising Suspicion for Evolving Secondary Hemophagocytic Lymphohistiocytosis in a Case of Mendelian Susceptibility to Mycobacterial Disease.
Soni D, Mukhopadhyay S, Panwar H, et al.
Diagnostic cytopathology 2026; (54(11)):E292-E295 doi:10.1002/dc.70186.
PMID: 42483808 - 41
Tailored conditioning for hematopoietic stem cell transplantation in children with Mendelian susceptibility to mycobacterial disease: A tale of two pathways for IFN-γ and IL-12 defects.
Ganesan K, Balwani M, Seshadri N, et al.
Journal of human immunity 2026; (2(5)):e20250264 doi:10.70962/jhi.20250264.
PMID: 42516312 - 42
Persistent Ascites Revealing Mendelian Susceptibility to Mycobacterial Disease Due to IL-12Rβ1 Deficiency: A Case Report and Review of the Literature.
Dolikhani M, Shakibamaram G, Rashtian P, et al.
Case reports in immunology 2026; (2026()):3587297 doi:10.1155/crii/3587297.
PMID: 42643649 - 43
Pediatric Mycobacterium bovis Infection: Clinical Spectrum, BCG-Related Disease, Primary Immunodeficiency, and a Comprehensive Review of the Literature.
Mete Atasever N, Dede E, Köksalan K, et al.
Vaccines 2026; (14(10)) doi:10.3390/vaccines14100867.
PMID: 42931396